{"id":"W4416139896","doi":"10.1093/neuonc/noaf201.1666","title":"TIP-06. A global, open-label, randomized Phase 3 trial evaluating niraparib compared to standard temozolomide therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Clinical endpoint; Radiation therapy; Clinical trial; Phases of clinical research; Randomized controlled trial; Quality of life (healthcare); Progression-free survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001991165,0.002094553,0.002517926,0.0005387358,0.000415878,0.00122938,0.001190093,0.001882477,0.01266447],"category_scores_gemma":[0.00160136,0.0006867753,0.002103319,0.0004651099,0.001191472,0.001524509,0.0005177902,0.00410885,0.002256982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006323309,"about_ca_system_score_gemma":0.001118392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004596605,"about_ca_topic_score_gemma":0.001455594,"domain_scores_codex":[0.9993783,0.000366725,0.00002818048,0.00009810489,0.00004032311,0.00008826801],"domain_scores_gemma":[0.9992148,0.000193482,0.0001509879,0.00005182996,0.00005527646,0.0003336476],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9651473,0.009616848,0.0006829329,0.0006433327,0.0006712198,0.00004168127,0.00004138571,0.0004827054,0.00321703,0.0001378955,0.002413563,0.01690405],"study_design_scores_gemma":[0.8998068,0.09668489,0.001439199,0.00003007291,0.0002218073,0.00004104959,0.00001720234,0.0004792597,0.0003125529,0.000180518,0.0007719517,0.00001467788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9702243,0.005187365,0.001179975,0.001476603,0.00096582,0.009486085,0.005459349,0.0003995337,0.005620876],"genre_scores_gemma":[0.964149,0.00336436,0.003628925,0.003277662,0.0007278149,0.01154631,0.00628609,0.00008201578,0.006937897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01266447,"threshold_uncertainty_score":0.04236686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04044565151742892,"score_gpt":0.3937761749243581,"score_spread":0.3533305234069292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}